0J2O.L · LSE

Halozyme Therapeutics, Inc.

WEAK

Momentum score based on proprietary multi-factor analysis

Last updated: Feb 27, 2026, 05:57 AM UTC

How is this calculated? →

Not investment advice. Learn more

Halozyme Therapeutics, Inc. Momentum Score — 33/100